Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Malaysian Palm Oil Board (Mpob) currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is distributed across 1 distinct examiner and 1 distinct art unit, indicating a concentrated prosecution footprint for the entity. The lack of diversity in examiners and art units suggests that the current legal focus is limited to a specific technical niche within the broader biotechnology sector.
The busiest examiner for this portfolio is BASQUILL, SEAN M, who is responsible for 1 pending office action. This examiner accounts for the entirety of the board's current pending workload. Practitioners should note that the concentration in 1 distinct art unit means that the board's immediate patent prospects are tied to the specific standards and practices of that unit. Because there is only 1 pending office action, any developments in this case will significantly impact the overall status of the board's active prosecution. The board's reliance on 1 distinct examiner for its current activity highlights the importance of understanding the individual review style of the assigned official.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BASQUILL, SEAN M | 1 | 38.8% | +21.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18201107 | PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS | BASQUILL, SEAN M | 24d overdue |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18201107 | PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 24d overdue | Pending | May 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial